؉ rhesus macaques were examined to compare the emergence of simian immunodeficiency virus (SIV)-specific CD8 ؉ T cells in the intestines and blood in early SIV infection using a major histocompatibility complex class I tetramer complexed with the Gag 181-189 peptide. Fourteen days after intravenous inoculation with SIVmac251, large numbers of SIV Gag 181-189 -specific CD8
Increasing evidence indicates that CD8
ϩ cytotoxic T lymphocytes (CTL) play a major role in the control of human immunodeficiency virus (HIV) infection (4, 15, 19, 24) . Detection of simian immunodeficiency virus (SIV)-or HIV-specific CTL responses in the blood in early infection often correlates with a reduction in viral loads, despite the absence of a detectable neutralizing antibody response (4, 15, 21, 25) . In addition, there is a significant inverse correlation between the number of HIV-specific CD8 ϩ T cells and the viral load in the peripheral blood in untreated patients (24) . Finally, depletion of CD8 ϩ T cells in macaques results in increases in viremia in both acute and chronic SIV infection during the period of maximal depletion (12, 29) .
HIV-or SIV-specific cytotoxic T cells have been demonstrated in a number of different tissues, including peripheral blood, bronchiolar lavage lymphocytes, lymph nodes, spleen, skin, liver, cerebrospinal fluid, thymus, bone marrow, intestine, and vaginal mucosa (4, 5, 10, 11, 15, 18, 20, 23, 27, 30, 31, 39) . To date, however, most of the data on CTL development in primary infection has been generated using either chromium release assays or limiting dilution analyses (20, 23, 39) . Since both of these methods require in vitro stimulation, these techniques yield relatively imprecise estimations of the actual number of virus-specific cells that exist in vivo (38) . Recently, a new approach to identify virus-specific CD8 ϩ T cells has been developed that utilizes soluble class I major histocompatibility complex (MHC)-peptide tetrameric complexes, which permit the direct visualization and quantification of antigen-specific T cells immediately ex vivo (3).
We and others have recently demonstrated that the intestinal tract is a major site of early SIV replication and the major site of CD4 ϩ T cell loss in primary SIV infection (13, 32, 35) . Rapid and profound CD4 ϩ T-cell depletion occurs specifically within the intestinal tract within 14 days of SIV infection, despite relatively stable CD4 ϩ T-cell counts in peripheral tissues. Coinciding with this CD4 ϩ T-cell loss, increased numbers of activated CD8 ϩ T cells appear in the intestinal tract in primary SIV infection (28, 37) . However, the extent to which SIV-specific CD8 ϩ T cells contribute to this increase in intestinal CD8 ϩ T cells is not known. Analysis of the emergence of SIV-specific CD8 ϩ T cells using MHC class I tetramers in primary SIV infection has demonstrated larger numbers of SIV-specific CD8 ϩ T cells in the blood than those in the lymph nodes (17) . However, little information is presently available on the kinetics of SIV-specific CD8 ϩ T-cell responses in gastrointestinal tissues during primary infection with SIV.
In this study we utilized tetrameric complexes of the Mamu-A*01 class I molecule and the SIV Gag 181-189 peptide (2) to identify SIV-specific CD8 ϩ T-cell responses in rhesus macaques acutely infected with SIVmac251. Three adult male macaques expressing the Mamu-A*01 class I allele were prospectively examined at 0, 7, 14, 21, and 63 days after infection, thus allowing a detailed comparison of the kinetics of SIVspecific CD8 ϩ T cells in peripheral blood and intestinal mucosa. Macaques were selected by screening for the presence of the Mamu-A*01 allele by PCR with sequence-specific primers as previously described (14) .
Animals were intravenously inoculated with SIVmac251 (50 ng of p27) on day 0. Endoscope-guided intestinal biopsies and peripheral blood mononuclear cells (PBMC) were collected before inoculation and at 0, 7, 14, 21, 35, and 63 days postinoculation (p.i.). To collect adequate numbers of intestinal lymphocytes for analyses, between 12 and 15 pinch biopsies (approximately 1 mm 3 each) of intestinal mucosa (duodenum and upper jejunum) were obtained at each time point using an Olympus endoscope and small biopsy forceps. These intestinal pinch biopsies were well tolerated in macaques, and no adverse events occurred as a result of these biopsies. Lymphocytes were isolated from intestinal biopsies as previously described (36, 37) .
For detection of SIV-specific CD8 ϩ T cells by flow cytometry, intestinal cells and PBMC were simultaneously stained with CD3-fluorescein isothiocyanate (FITC) (clone SP34; PharMingen), CD8-peridinin chlorophyll protein (PerCP) (Leu-2a; Becton Dickinson), and the tetrameric complex coupled to allophycocyanin (APC). To determine CD4 counts, parallel samples were stained with CD3-FITC, CD8-PerCP, and CD4-APC (Becton Dickinson). Data on chemokine receptor expression by CD4 ϩ T cells on these animals has previously been reported (36) . These cells were stained at 4°C in the dark for 30 min, washed, and fixed overnight in 2% paraformaldehyde. Cells were acquired with a FACS Calibur flow cytometer (Becton Dickinson) and analyzed with Cell Quest software (Becton Dickinson). In general, a total of 200,000 events were acquired, and analysis of tetramer staining cells was carried out on CD3 ϩ CD8 ϩ gated lymphocytes. No significant SIV Gag 181-189 -specific CD8 ϩ T-cell response was detected in the peripheral blood or intestine of any of the macaques at day 7 p.i. However, in all three macaques relatively large percentages (between 3.1 to 13.4% of CD3 ϩ CD8 ϩ lymphocytes) of SIV Gag 181-189 -specific CD8 ϩ T cells were detected in both the intestinal mucosa and in the peripheral blood by 14 days p.i. (Fig. 1) . Although the percentages were slightly higher for the intestines than for the PBMC in 2 out of 3 of the macaques at day 14, the percentages of intestinal SIV Gag 181-189 -specific CD8 ϩ T cells closely reflected those in the peripheral blood at this time point. However, by day 21 p.i., levels of tetramer-binding cells had markedly decreased in both the blood and intestine compared to those at day 14 in all three animals (Fig. 1) .
Surprisingly, however, SIV Gag 181-189 -specific CD8 ϩ T-cell responses in the intestine appeared to increase by 63 days p.i. compared to those at day 21. Moreover, SIV Gag 181-189 -specific CD8
ϩ T-cell levels were significantly higher in the intestines at this time point than in peripheral blood for all three macaques (P Ͻ 0.05; Mann Whitney U test, performed using StatView; Abacus Concepts, Berkely, Calif.) (Fig. 1) at day 63. Interestingly, this was the macaque that had the lowest percentage at day 14 p.i. Intestinal SIV-specific CD8 ϩ T cells in the other two macaques approached peak levels previously attained on day 14 p.i. (Fig. 1) . In contrast, levels of SIV Gag 181-189 -specific CD8 ϩ T cells in Mm353 and Mm356 were lower in PBMC at day 63 than at day 14 p.i., consistent with previous reports that have shown peak levels of tetramer-binding cells at around 13 days p.i. (16) .
As expected, marked intestinal CD4 ϩ T-cell depletion was evident in all three animals by 14 days p.i., reaching a nadir by 21 days p.i. (Table 1 ). The depletion of CD4 ϩ T cells was equally evident in examination of both total intestinal lymphocytes (Table 1 ) and gated CD3 ϩ T cells (36) . In contrast, only minor changes in CD4 ϩ T cells were observed in the blood for these early time points (Table 1) . Macaque Mm356 showed a moderate decrease in CD4 ϩ T cells at day 14 p.i., yet by days 21 and 63 they were essentially back to preinfection levels ( Table 1) .
Quantitation of SIV viral RNA levels in plasma were determined by real-time reverse transcriptase-PCR as previously described (34) . Only slight differences in viral loads were detected in the three animals after infection. Peak viremia occurred by day 14 in all three macaques and steadily declined thereafter in all three animals until day 63, when Mm356 showed a modest increase in viral load (Fig. 2) . Interestingly, this macaque consistently had higher viral loads throughout the course of the study (Fig. 2) . Viral loads in all macaques were similar to those previously published for other macaques infected with the same viral strain and route of inoculation (7, 33) .
These data reinforce the concept that the intestinal lymphoid tissue is a major target of HIV and SIV infection. Moreover, the observation that relatively equal percentages of SIVspecific CD8 ϩ T cells are found in the peripheral blood and intestines in early infection contrasts with that observed in lymph nodes, where percentages of tetramer-binding cells have been shown to be lower than those in blood in primary infection (16) .
The intestinal tract is the largest lymphoid organ in the body (22) . It has been estimated that the intestinal epithelium alone contains 60% of the total T cells in the body (9, 22) . Therefore, lymphocytes in gastrointestinal lymphoid tissues are, at least numerically, the most significant part of the immune system (22) . Thus, the demonstration of equal (day 14) or higher (day 63) percentages of SIV Gag 181-189 -specific CD8 ϩ T cells in the intestinal mucosa and blood suggests that the majority of HIVor SIV-specific CD8 ϩ T cells resides in gut-associated lymphoid tissues. This is not entirely surprising, since it is well established that most of the early viral replication and CD4 ϩ T-cell depletion occurs in the intestinal tract in early SIV infection (13, 32, 35) .
Although SIV-specific CD8 ϩ T cells developed early in infection in all three animals, marked differences in the magnitude of the CD8 ϩ response were detected among individual animals. Macaque Mm356 consistently had the highest frequency of SIV Gag 181-189 -specific T cells in both blood and intestines through day 21 p.i. Interestingly, this macaque also had the highest viral load at day 7. Higher early viral loads in the blood of this macaque may have triggered the strong development and persistence of SIV-specific CD8
ϩ T cells at later time points. Mm352 had the lowest frequency of SIV Gag 181-189 -specific CD8 ϩ T cells until day 63, when large percentages appeared in the intestine. This macaque also had the lowest viral loads at day 7. In all three macaques there was a positive relationship between viral loads and the percentage of SIV-specific CD8 ϩ T cells in the blood in individual macaques. However, the percentages of SIV Gag 181-189 -specific CD8 ϩ T cells in the intestines were higher at day 63 than at day 21, an increase which occurred coincident with a decrease in the viral load between these time points. Although CD4 ϩ T cells were depleted by 21 days p.i., a slight rebound in CD4 ϩ T cells was observed between days 21 and 63 (Table 1) was associated with an increase in intestinal SIV Gag 181-189 -specific CD8 ϩ T cells (Fig. 1) . Further studies will be necessary to confirm these observations and to elucidate the mechanisms behind regional variations in SIV-specific CD8 ϩ T-cell development.
Although the numbers of SIV-specific CD8 ϩ T cells reported here are relatively high, these numbers do not fully account for the marked increase in CD8 ϩ T cells observed in HIV-infected patients (26) or SIV-infected macaques (28, 37) . However, in this report we only examined the CD8 ϩ T-cell specificity to a single SIV epitope (SIV Gag 181-189 ), and it is clear that CTL recognize a number of different epitopes in SIV infection (1, 6, 8) . In fact, analysis of MamuA*01 ϩ macaques infected with SIV has shown that there is a higher frequency of CD8 ϩ T cells specific for the Tat [28] [29] [30] [31] [32] [33] [34] [35] than for the SIV Gag 181-189 epitope in the first 4 to 6 weeks after infection (1) . Thus, the magnitude of the SIV-specific CD8 ϩ T-cell response is likely to be several-fold higher than that observed here using tetramers complexed with the Gag 181-189 epitope.
In summary, the finding of high frequencies of SIV-specific CD8 ϩ T cells in the intestinal tract early in SIV infection provides additional evidence that the intestinal tract is the major target organ in early HIV and SIV infection.
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